Page last updated: 2024-08-25

tetrandrine and Cardiac Remodeling, Ventricular

tetrandrine has been researched along with Cardiac Remodeling, Ventricular in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Belke, DD; Duff, HJ; Fedak, PW; Mewhort, HE; Svystonyuk, D; Teng, G; Turnbull, JD	1
Chen, C; Dong, W; Lin, X; Lv, S; Tong, G; Wang, X; Yang, D; Yang, Y	1
Rao, MR	1

Reviews

1 review(s) available for tetrandrine and Cardiac Remodeling, Ventricular

Article	Year
Effects of tetrandrine on cardiac and vascular remodeling. Acta pharmacologica Sinica, 2002, Volume: 23, Issue:12 Topics: Alkaloids; Animals; Antihypertensive Agents; Apoptosis; Benzylisoquinolines; Calcium; Cardiovascular System; Humans; Muscle, Smooth, Vascular; Sodium-Potassium-Exchanging ATPase; Ventricular Remodeling	2002

Other Studies

2 other study(ies) available for tetrandrine and Cardiac Remodeling, Ventricular

Article	Year
Tetrandrine reverses human cardiac myofibroblast activation and myocardial fibrosis. American journal of physiology. Heart and circulatory physiology, 2015, Jun-15, Volume: 308, Issue:12 Topics: Actins; Animals; Atrial Appendage; Benzylisoquinolines; Calcium; Calcium Channel Blockers; Calcium Chelating Agents; Cardiomyopathies; Cells, Cultured; Collagen; Dose-Response Relationship, Drug; Fibrosis; Gels; Humans; Hypertension; Male; Myofibroblasts; Rats, Inbred Dahl; Time Factors; Ventricular Function, Left; Ventricular Remodeling	2015
Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1. Journal of vascular surgery, 2016, Volume: 64, Issue:5 Topics: Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Antioxidants; Arterial Pressure; Benzylisoquinolines; Catalase; Cell Proliferation; Cyclic GMP-Dependent Protein Kinase Type I; Disease Models, Animal; Glutathione; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Malondialdehyde; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide Synthase Type II; Oxidative Stress; Pulmonary Artery; Rats, Sprague-Dawley; Signal Transduction; Superoxide Dismutase; Time Factors; Vascular Remodeling; Ventricular Remodeling	2016

Article

Year

Tetrandrine reverses human cardiac myofibroblast activation and myocardial fibrosis.

American journal of physiology. Heart and circulatory physiology, 2015, Jun-15, Volume: 308, Issue:12

Topics: Actins; Animals; Atrial Appendage; Benzylisoquinolines; Calcium; Calcium Channel Blockers; Calcium Chelating Agents; Cardiomyopathies; Cells, Cultured; Collagen; Dose-Response Relationship, Drug; Fibrosis; Gels; Humans; Hypertension; Male; Myofibroblasts; Rats, Inbred Dahl; Time Factors; Ventricular Function, Left; Ventricular Remodeling

2015

Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.

Journal of vascular surgery, 2016, Volume: 64, Issue:5

Topics: Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Antioxidants; Arterial Pressure; Benzylisoquinolines; Catalase; Cell Proliferation; Cyclic GMP-Dependent Protein Kinase Type I; Disease Models, Animal; Glutathione; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Malondialdehyde; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide Synthase Type II; Oxidative Stress; Pulmonary Artery; Rats, Sprague-Dawley; Signal Transduction; Superoxide Dismutase; Time Factors; Vascular Remodeling; Ventricular Remodeling

2016